These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 996920)

  • 41. A novel B(weak) hybrid allele lacks three enhancer repeats but generates normal ABO transcript levels.
    Thuresson B; Hosseini-Maaf B; Hult AK; Hustinx H; Alan Chester M; Olsson ML
    Vox Sang; 2012 Jan; 102(1):55-64. PubMed ID: 21592135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of weak antigens of the abo system by the method of absorption-elution with heteroimmune anti-A and anti-B sera].
    Iudina GS; Prozorovskaia GP
    Sud Med Ekspert; 1974; 17(4):21-2. PubMed ID: 4615400
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the demonstration of blood group antigens A and B in human spermatozoa].
    Karsznia R; Spielmann W; Trinkaus J
    Gynaecologia; 1969; 167(1):14-22. PubMed ID: 5788916
    [No Abstract]   [Full Text] [Related]  

  • 44. [An example of chromosome cis A1B. Immunologic and genetic study of the induced phenotype].
    Reviron J; Jacquet A; Salmon C
    Nouv Rev Fr Hematol; 1968; 8(3):323-38. PubMed ID: 4234494
    [No Abstract]   [Full Text] [Related]  

  • 45. [An acquired B antigen in a subject of A2 group].
    Andreu G; Mativet S; Simonneau M; Pierre J; Salmon C
    Rev Fr Transfus Immunohematol; 1978 Feb; 21(1):185-92. PubMed ID: 653206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase.
    Hosseini-Maaf B; Letts JA; Persson M; Smart E; LePennec PY; Hustinx H; Zhao Z; Palcic MM; Evans SV; Chester MA; Olsson ML
    Transfusion; 2007 May; 47(5):864-75. PubMed ID: 17465952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Quantitative studies of the ABO blood group system. Quantitative changes in agglutinability of antigens A, B and H with regard to the patient's age].
    Prodanov P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):436-51. PubMed ID: 72031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunochemical studies on blood groups.XLIX. The I antigen complex: specificity differences among anti-I sera revealed by quantitative precipitin studies; partial structure of the I determinant specific for one anti-I serum.
    Feizi T; Kabat EA; Vicari G; Anderson B; Marsh WL
    J Immunol; 1971 Jun; 106(6):1578-92. PubMed ID: 4103724
    [No Abstract]   [Full Text] [Related]  

  • 49. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer.
    Hakomori S
    Biochim Biophys Acta; 1999 Dec; 1473(1):247-66. PubMed ID: 10580143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood type AB in the feline AB blood group system.
    Griot-Wenk ME; Callan MB; Casal ML; Chisholm-Chait A; Spitalnik SL; Patterson DF; Giger U
    Am J Vet Res; 1996 Oct; 57(10):1438-42. PubMed ID: 8896680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant activity of erythrocyte isoantigens.
    Schierman LW; McBride RA
    Science; 1967 May; 156(3775):658-9. PubMed ID: 6023661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substances in serum causing interference with blood group determination.
    Treacy M; Geiger J; Goss MF
    Transfusion; 1967; 7(6):443-6. PubMed ID: 4965289
    [No Abstract]   [Full Text] [Related]  

  • 53. The cis-AB blood group phenotype: fundamental lessons in glycobiology.
    Yazer MH; Olsson ML; Palcic MM
    Transfus Med Rev; 2006 Jul; 20(3):207-17. PubMed ID: 16787828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression].
    Yang SC
    Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):631-3, 639. PubMed ID: 2086062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoantigens of the H-2 and Tla loci of the mouse: interactions affecting their representation on thymocytes.
    Boyse EA; Stockert E; Old LJ
    J Exp Med; 1968 Jul; 128(1):85-95. PubMed ID: 5662018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ABO antigens and enzymes. As an introduction.
    Salmon C
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):17-23. PubMed ID: 788102
    [No Abstract]   [Full Text] [Related]  

  • 57. A QUANTITATIVE IMMUNOGENETIC STUDY OF GENE SUPPRESSION INVOLVING A1 AND H ANTIGENS OF THE ERYTHROCYTE WITHOUT AFFECTING SECRETED BLOOD GROUP SUBSTANCES. THE ABH PHENOTYPES AHM AND OHM.
    SOLOMON JM; WAGGONER R; LEYSHON WC
    Blood; 1965 Apr; 25():470-85. PubMed ID: 14284336
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cad antigen in the French population].
    Gerbal A; Lopez M; Chassaigne M; Genetet B; Selva J; Yvart J; Salmon C
    Rev Fr Transfus Immunohematol; 1976 Sep; 19(3):415-29. PubMed ID: 1006051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Actual problems of the H blood group immunogenetics (author's transl)].
    Hrubisko M
    Wien Klin Wochenschr; 1980 Nov; 92(21):747-9. PubMed ID: 7467351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Deficit of erythrocyte antigens as a cause of pathology. IV. Weak ABO phenotypes. Ax and Bx phenotypes].
    Gómez Casal F; Poderós Baeta C; Romero Colas MS; Soler Mantilla H; Fuertes Palacio MA; Callén Sevilla L; Gutiérrez Martín M
    Rev Clin Esp; 1983 Dec; 171(6):441-2. PubMed ID: 6672881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.